Heart attack patients: can a common gout pill improve bypass recovery?

NCT ID NCT05726019

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether the anti-inflammatory drug colchicine can reduce complications like irregular heartbeat, heart sac inflammation, and heart damage after coronary artery bypass surgery. 100 patients who had a recent heart attack and needed bypass surgery were randomly assigned to receive colchicine or a placebo for 30 days after surgery. The goal was to see if colchicine could improve recovery and prevent common post-surgery problems.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY BYPASS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute coronary syndrome atherosclerosis atrial fibrillation coronary artery disorder ischemia reperfusion injury myocardial infarction Postpericardiotomy Syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Heart Institute - University of São Paulo

    São Paulo, São Paulo, 05403000, Brazil